By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is that SES's recent revenue growth is impressive but not sustainable given its small base and high cash burn. The 'Molecular Universe' AI platform is seen as a potential moat, but its ability to generate meaningful revenue and offset hardware risks is uncertain. The company's valuation is considered high, with a forward revenue multiple north of 38x.
Risk: Continued cash burn if the 'Molecular Universe' AI platform stalls and OEMs don't pay for discovery tools, leaving SES with hardware risk and dilution without a scalable software moat to justify the valuation.
Opportunity: Successfully monetizing material discovery as a service through the 'Molecular Universe' AI platform, potentially pivoting to a high-margin software-like model.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
SES AI Corporation (NYSE:SES) is one of the best EV battery stocks to buy in 2026. On April 24, Cantor Fitzgerald analyst Derek Soderberg reiterated his Overweight rating and $4 price target on SES AI Corporation (NYSE:SES). The call came after SES shared its Q1 FY2026 earnings results.
In the results, SES said quarterly revenue reached $6.7 million, a 47% jump from the previous quarter, and that this growth came on the back of robust performance by the Energy Storage Systems (ESS) segment. The company reported a non-GAAP loss of $0.03 per share during the quarter, which was in line with analyst forecasts. Over the past twelve months, SES’s total revenue surged 929% to reach $21 million.
Beside the remarkable quarter, Soderberg also noted that his optimism about the company arises from its new multi-year distribution agreement with ATG EPower. ATG EPower is a private global battery manufacturer, and the agreement covers North American distribution of its energy storage products, which is valued at about $20 million over three years.
On the technology side, the analyst noted that SES’s Molecular Universe (MU) unit, which uses artificial intelligence to discover new battery materials, continued to gain traction. About half a dozen of the company’s customers now progress into the second phase of testing for MU-discovered materials, noted Soderberg. He added that this signals growing commercial interest beyond the core ESS business.
SES AI Corporation (NYSE:SES) is a battery technology company that develops lithium-metal batteries for use in electric vehicles. It focuses on next-generation battery chemistries designed to improve energy density, performance, and efficiency compared to conventional lithium-ion batteries.
While we acknowledge the potential of SES as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Large Cap Penny Stocks Under $10 to Buy Now and 8 Best Silver Mining Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"The company's valuation is currently driven by speculative AI-discovery potential rather than the fundamental economics of its low-margin energy storage business."
SES AI’s 929% year-over-year revenue growth is a classic 'small base' effect, not a structural shift in profitability. While the $20 million ATG EPower deal provides a revenue floor, it is negligible against the company’s cash burn and capital expenditure requirements for lithium-metal R&D. The real value isn't the ESS revenue, but the 'Molecular Universe' AI platform. If they can successfully monetize material discovery as a service, they pivot from a capital-intensive manufacturer to a high-margin software-like model. However, the $4 price target assumes near-perfect execution in a sector where commercializing next-gen battery chemistry historically takes a decade longer than management forecasts.
The company may never achieve the scale required for mass-market lithium-metal production, rendering their AI discovery platform a 'solution in search of a problem' while they bleed cash.
"SES's revenue surge masks a tiny base and massive scaling hurdles for lithium-metal batteries, leaving profitability distant amid high cash burn."
SES's 929% TTM revenue growth to $21M sounds explosive but starts from a microscopic $2.3M base, with Q1's $6.7M still trivial for an EV battery contender needing billions in capex to scale. Non-GAAP EPS loss of $0.03/share met low expectations but signals persistent cash burn amid R&D-heavy lithium-metal tech, prone to dendrite formation and unproven cycle life at volume. The $20M/3yr ATG deal and AI materials traction are promising, yet commercialization remains years out in a cutthroat sector (QS, SLDP). Valuation at ~25x TTM sales (assuming ~$500M mkt cap) embeds huge risk premium with dilution likely.
SES's ESS revenue ramp and half-dozen customers advancing AI-discovered materials to phase 2 testing mark an inflection toward multi-year growth, amplified by EV megatrends and Cantor's $4 PT signaling 100%+ upside.
"SES has genuine early-stage traction in next-gen batteries and AI material discovery, but current valuation assumes flawless execution and sustained hypergrowth; downside risk is asymmetric if quarterly growth normalizes or cash burn accelerates."
SES's 929% YoY revenue growth is eye-catching, but $21M annualized revenue on a public company trading at market cap ~$800M+ implies a forward revenue multiple north of 38x — unsustainable without accelerating growth. The Q1 beat is real: $6.7M quarterly, 47% QoQ growth, and the ATG EPower deal ($20M/3yr) provides visibility. However, the company is still cash-flow negative at scale, and the Molecular Universe AI unit shows early traction (six customers in phase 2) but zero disclosed revenue. Cantor's $4 target lacks disclosed DCF assumptions. The article itself hedges by redirecting readers to 'better AI stocks,' which is a red flag about conviction.
If SES's growth rate decelerates to 30-40% annually (still exceptional) and the company burns cash reaching profitability, the valuation multiple compresses 50%+ regardless of technology merit. The ATG EPower deal, while material, is only $6.7M/year — a rounding error relative to current market expectations.
"SES's upside hinges on multiple uncertain milestones aligning (revenue from MU/ESS, scale, and profitable operations); without near-term profitability, the stock remains a high-risk, speculative bet."
SES's Q1 shows revenue of $6.7M and a 929% YoY surge to $21M annual revenue, but the base remains tiny and profitability is unproven. The bull case rests on a $20M three-year distribution deal with ATG EPower and early MU AI-discovery traction; neither guarantees meaningful revenue or margin expansion. The company is still non-GAAP negative and likely burning cash while scale and customer adoption lag. With a small capital base, execution risk, and competition in lithium-metal battery tech, the upside is highly contingent on several milestones—milestones that are far from assured.
MU progress may never translate into material revenue, and the ATG deal could be back-end loaded or non-binding; the stock’s price may already reflect optimistic assumptions that don’t materialize.
"The Molecular Universe AI platform functions as a strategic hedge for an M&A exit if the lithium-metal manufacturing process fails to reach commercial scale."
Claude is right about the valuation, but everyone is missing the 'Molecular Universe' pivot's true intent: it’s a defensive moat, not a revenue engine. By licensing AI-driven material discovery, SES is attempting to become the 'Nvidia of battery chemistry' to offset their manufacturing failure risk. If the lithium-metal hardware fails to scale, the IP portfolio becomes the primary asset for an M&A exit to a legacy automotive OEM, providing a floor that pure-play battery manufacturers lack.
"OEMs prefer JVs over M&A for unproven battery IP like SES's, heightening dilution risk."
Gemini, your M&A moat via Molecular Universe ignores OEM incentives: partners like GM pour billions into in-house solid-state (e.g., via SolidEnergy Systems JV) and favor low-cost JVs over acquiring $500M-cap, cash-burning lithium-metal speculators with dendrite-prone tech. SES risks dilution spirals before any 'Nvidia' pivot materializes, amplifying burn rate risks everyone flags.
"SES's defensibility hinges on MU licensing revenue, not M&A optionality—and early customer traction masks zero disclosed revenue from that unit."
Grok's OEM-incentive argument is sound, but misses SES's actual leverage: they're not pitching M&A to GM—they're selling material-discovery licenses to battery suppliers *competing against* GM's captive programs. If MU identifies a dendrite-resistant electrolyte before SolidEnergy's in-house team, SES becomes a supplier, not an acquisition target. The real risk isn't dilution spirals; it's that MU's six phase-2 customers never convert to paying contracts, leaving SES as a cash-burning hardware play with no moat.
"MU monetization risk means SES may have no scalable moat and the high valuation may not be justified."
Claude's call on a 38x forward revenue multiple is a caution, but the bigger flaw is treating MU as a moat. Six phase-2 customers are not revenue; even if licenses materialize, the ramp is unproven and back-loaded. The real risk is continued cash burn if MU stalls and OEMs don't pay for discovery tools, leaving SES with hardware risk and dilution without a scalable software moat to justify the valuation.
The panel consensus is that SES's recent revenue growth is impressive but not sustainable given its small base and high cash burn. The 'Molecular Universe' AI platform is seen as a potential moat, but its ability to generate meaningful revenue and offset hardware risks is uncertain. The company's valuation is considered high, with a forward revenue multiple north of 38x.
Successfully monetizing material discovery as a service through the 'Molecular Universe' AI platform, potentially pivoting to a high-margin software-like model.
Continued cash burn if the 'Molecular Universe' AI platform stalls and OEMs don't pay for discovery tools, leaving SES with hardware risk and dilution without a scalable software moat to justify the valuation.